Cargando…
Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment
The aim of the study was the evaluation of the suitability of 5-oxo-2-pyrrolidinecarboxylic acid (PCA), also in combination with hyaluronic acid (HA), as artificial tears for treatment of dry eye syndrome (DES). Different aqueous formulations containing 0.10% w/w of PCA were used to determine: (i) e...
Autores principales: | Tampucci, Silvia, Monti, Daniela, Burgalassi, Susi, Terreni, Eleonora, Zucchetti, Erica, Baldacci, Filippo, Chetoni, Patrizia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161197/ https://www.ncbi.nlm.nih.gov/pubmed/30149648 http://dx.doi.org/10.3390/pharmaceutics10030137 |
Ejemplares similares
-
Combination of Nanomicellar Technology and In Situ Gelling Polymer as Ocular Drug Delivery System (ODDS) for Cyclosporine-A
por: Terreni, Eleonora, et al.
Publicado: (2021) -
Ocular Application of Oleuropein in Dry Eye Treatment: Formulation Studies and Biological Evaluation
por: Burgalassi, Susi, et al.
Publicado: (2021) -
Development and Characterization of a Novel Peptide-Loaded Antimicrobial Ocular Insert
por: Terreni, Eleonora, et al.
Publicado: (2020) -
Hydrogels as Corneal Stroma Substitutes for In Vitro Evaluation of Drug Ocular Permeation
por: Burgalassi, Susi, et al.
Publicado: (2022) -
Binary Polymeric Surfactant Mixtures for the Development of Novel Loteprednol Etabonate Nanomicellar Eyedrops
por: Tampucci, Silvia, et al.
Publicado: (2023)